MA54714A - Formulation de nicotine - Google Patents
Formulation de nicotineInfo
- Publication number
- MA54714A MA54714A MA054714A MA54714A MA54714A MA 54714 A MA54714 A MA 54714A MA 054714 A MA054714 A MA 054714A MA 54714 A MA54714 A MA 54714A MA 54714 A MA54714 A MA 54714A
- Authority
- MA
- Morocco
- Prior art keywords
- nicotine formulation
- nicotine
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Manufacture Of Tobacco Products (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18175640.4A EP3574902A1 (fr) | 2018-06-01 | 2018-06-01 | Formulation de nicotine et mode d'administration |
Publications (1)
Publication Number | Publication Date |
---|---|
MA54714A true MA54714A (fr) | 2021-11-17 |
Family
ID=62528283
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA054714A MA54714A (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
MA50205A MA50205B1 (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA50205A MA50205B1 (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
Country Status (13)
Country | Link |
---|---|
US (2) | US11833145B2 (fr) |
EP (3) | EP3574902A1 (fr) |
JP (1) | JP7224375B2 (fr) |
CN (1) | CN112218637A (fr) |
AU (2) | AU2019276357B2 (fr) |
BR (1) | BR112020024088B1 (fr) |
CA (1) | CA3099940A1 (fr) |
ES (1) | ES2883799T3 (fr) |
MA (2) | MA54714A (fr) |
MX (1) | MX2020012810A (fr) |
PL (1) | PL3684362T3 (fr) |
SG (1) | SG11202011761XA (fr) |
WO (1) | WO2019229249A1 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3574902A1 (fr) * | 2018-06-01 | 2019-12-04 | Yatzz Limited | Formulation de nicotine et mode d'administration |
GB201817863D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
GB201817859D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
GB201817867D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
GB201817868D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolised formulation |
GB201817860D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolised formulation |
GB201817865D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
KR20210108390A (ko) * | 2018-12-31 | 2021-09-02 | 필립모리스 프로덕츠 에스.에이. | 저점도 액체 니코틴 제형 |
EP3905908B1 (fr) | 2019-06-20 | 2025-01-08 | Shaheen Innovations Holding Limited | Dispositif d'atomisation à ultrasons personnel |
FR3102041B1 (fr) * | 2019-10-22 | 2025-02-14 | Aroma Sens | Edulcorant pour liquides de cigarette électronique |
JP7578712B2 (ja) | 2019-12-15 | 2024-11-06 | シャヒーン イノベーションズ ホールディング リミテッド | 超音波ミスト吸入器 |
US11666713B2 (en) | 2019-12-15 | 2023-06-06 | Shaheen Innovations Holding Limited | Mist inhaler devices |
US12121056B2 (en) | 2019-12-15 | 2024-10-22 | Shaheen Innovations Holding Limited | Hookah device |
ES2982684T3 (es) | 2019-12-15 | 2024-10-17 | Shaheen Innovations Holding Ltd | Inhalador de nebulización ultrasónico |
EP3855949A1 (fr) | 2019-12-15 | 2021-08-04 | Shaheen Innovations Holding Limited | Inhalateur de brume ultrasonore |
US11589610B2 (en) | 2019-12-15 | 2023-02-28 | Shaheen Innovations Holding Limited | Nicotine delivery device having a mist generator device and a driver device |
US11730193B2 (en) | 2019-12-15 | 2023-08-22 | Shaheen Innovations Holding Limited | Hookah device |
US12201144B2 (en) | 2019-12-15 | 2025-01-21 | Shaheen Innovations Holding Limited | Hookah device |
KR102725481B1 (ko) | 2019-12-15 | 2024-11-06 | 샤힌 이노베이션즈 홀딩 리미티드 | 초음파 미스트 흡입장치 |
US11730191B2 (en) | 2019-12-15 | 2023-08-22 | Shaheen Innovations Holding Limited | Hookah device |
AU2020410172B2 (en) | 2019-12-15 | 2023-02-23 | Shaheen Innovations Holding Limited | Mist inhaler devices |
EP4076025A1 (fr) * | 2019-12-18 | 2022-10-26 | Philip Morris Products, S.A. | Formulation destinée à être utilisée dans un système de génération d'aérosol |
JP7609561B2 (ja) * | 2020-02-05 | 2025-01-07 | 日本たばこ産業株式会社 | 液体加熱式の加熱型香味吸引器用の液体組成物 |
CA3172852A1 (fr) | 2020-03-27 | 2021-09-30 | Mcneil Ab | Cartouche contenant de la nicotine |
MA65146B1 (fr) * | 2020-04-06 | 2024-05-31 | Shaheen Innovations Holding Ltd | Dispositifs d'inhalateur de brouillard |
CN111802686A (zh) * | 2020-07-27 | 2020-10-23 | 湖北中烟工业有限责任公司 | 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟 |
CN111855866A (zh) * | 2020-08-25 | 2020-10-30 | 甘肃烟草工业有限责任公司 | 一种快速测定烟用添加剂中甲醛的方法 |
IL303786B2 (en) * | 2020-12-15 | 2024-07-01 | Shaheen Innovations Holding Ltd | Mist inhaler devices |
CN113197330A (zh) * | 2021-04-28 | 2021-08-03 | 深圳市博睿生物科技有限公司 | 一种电子烟新型甜味剂及制备方法及应用 |
IL283002A (en) * | 2021-05-06 | 2022-12-01 | Nicogen Ltd | Nicotine formulations and aerosols |
CN113912585B (zh) * | 2021-11-09 | 2023-02-24 | 深圳萨特瓦生物科技有限公司 | 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟 |
US20230188901A1 (en) | 2021-12-15 | 2023-06-15 | Shaheen Innovations Holding Limited | Apparatus for transmitting ultrasonic waves |
CN116019250B (zh) * | 2022-12-22 | 2025-02-14 | 东莞市吉纯生物技术有限公司 | 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法 |
WO2024138377A1 (fr) * | 2022-12-27 | 2024-07-04 | 思摩尔国际控股有限公司 | Liquide d'atomisation, atomiseur et dispositif d'atomisation électronique |
WO2024161313A1 (fr) * | 2023-01-31 | 2024-08-08 | Rai Strategic Holdings, Inc. | Formulations de précurseur d'aérosol stabilisées |
CN118787123A (zh) * | 2023-04-14 | 2024-10-18 | 思摩尔国际控股有限公司 | 一种水基电子烟雾化制剂及其制备方法和应用 |
CN117898466B (zh) * | 2024-02-29 | 2024-09-24 | 深圳市艾斯摩迪斯科技有限公司 | 一种复合尼古丁盐的制备方法及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2133691B (en) * | 1983-01-21 | 1986-05-21 | Leo Ab | Smoking substitutes for nasal administration |
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
CA2231968A1 (fr) * | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Methode de production d'un medicament a base de nicotine |
US7767698B2 (en) * | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
SE0201669D0 (sv) * | 2002-06-03 | 2002-06-03 | Pharmacia Ab | New formulation and use thereof |
GB0712308D0 (en) * | 2007-06-25 | 2007-08-01 | Kind Group Ltd | An inhalable composition |
CN114223927A (zh) * | 2013-05-06 | 2022-03-25 | 尤尔实验室有限公司 | 用于气溶胶装置的烟碱盐调配物及其方法 |
UA122320C2 (uk) * | 2013-07-19 | 2020-10-26 | Олтріа Клайєнт Сервісиз Ллк | Рідка аерозольна композиція для електронного курильного виробу |
DE102015117811A1 (de) * | 2015-10-20 | 2017-04-20 | Chv Pharma Gmbh & Co. Kg | Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator |
EP3574902A1 (fr) * | 2018-06-01 | 2019-12-04 | Yatzz Limited | Formulation de nicotine et mode d'administration |
-
2018
- 2018-06-01 EP EP18175640.4A patent/EP3574902A1/fr not_active Withdrawn
-
2019
- 2019-05-31 AU AU2019276357A patent/AU2019276357B2/en active Active
- 2019-05-31 MA MA054714A patent/MA54714A/fr unknown
- 2019-05-31 SG SG11202011761XA patent/SG11202011761XA/en unknown
- 2019-05-31 CN CN201980034986.5A patent/CN112218637A/zh active Pending
- 2019-05-31 ES ES19727687T patent/ES2883799T3/es active Active
- 2019-05-31 WO PCT/EP2019/064212 patent/WO2019229249A1/fr active Application Filing
- 2019-05-31 EP EP21174043.6A patent/EP3909581A1/fr active Pending
- 2019-05-31 EP EP19727687.6A patent/EP3684362B1/fr active Active
- 2019-05-31 JP JP2020567039A patent/JP7224375B2/ja active Active
- 2019-05-31 BR BR112020024088-5A patent/BR112020024088B1/pt active IP Right Grant
- 2019-05-31 US US17/057,700 patent/US11833145B2/en active Active
- 2019-05-31 MA MA50205A patent/MA50205B1/fr unknown
- 2019-05-31 CA CA3099940A patent/CA3099940A1/fr active Pending
- 2019-05-31 PL PL19727687T patent/PL3684362T3/pl unknown
- 2019-05-31 MX MX2020012810A patent/MX2020012810A/es unknown
-
2023
- 2023-05-08 AU AU2023202855A patent/AU2023202855B2/en active Active
- 2023-10-26 US US18/495,012 patent/US20240050424A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3574902A1 (fr) | 2019-12-04 |
MA50205B1 (fr) | 2021-09-30 |
AU2019276357B2 (en) | 2023-04-20 |
MX2020012810A (es) | 2022-03-08 |
NZ769793A (en) | 2024-05-31 |
BR112020024088B1 (pt) | 2022-10-11 |
EP3684362A1 (fr) | 2020-07-29 |
WO2019229249A1 (fr) | 2019-12-05 |
JP7224375B2 (ja) | 2023-02-17 |
PL3684362T3 (pl) | 2021-12-20 |
EP3684362B1 (fr) | 2021-06-23 |
ES2883799T3 (es) | 2021-12-09 |
AU2023202855A1 (en) | 2023-05-25 |
BR112020024088A2 (pt) | 2021-02-17 |
US20210196700A1 (en) | 2021-07-01 |
EP3909581A1 (fr) | 2021-11-17 |
JP2021526147A (ja) | 2021-09-30 |
CA3099940A1 (fr) | 2019-12-05 |
AU2023202855B2 (en) | 2024-08-22 |
US11833145B2 (en) | 2023-12-05 |
MA50205A (fr) | 2020-07-29 |
SG11202011761XA (en) | 2020-12-30 |
AU2019276357A1 (en) | 2020-11-26 |
CN112218637A (zh) | 2021-01-12 |
US20240050424A1 (en) | 2024-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA54714A (fr) | Formulation de nicotine | |
DK3688162T3 (da) | Formuleringer | |
EP3818843A4 (fr) | Cigarette | |
MA50657A (fr) | Formulations de niraparib | |
EP3818840A4 (fr) | Cigarette | |
PL3703518T3 (pl) | Formulacja ulegająca aerozolowaniu | |
DK3651736T3 (da) | Langtidsvirkende formuleringer | |
DK3768669T3 (da) | Piperazinazaspiroderivater | |
EP3905900C0 (fr) | Formulation de nicotine liquide | |
EP3454847A4 (fr) | Formulations de médicaments améliorées | |
MA50068A (fr) | Formulations de copanlisib | |
HUE061610T2 (hu) | Készítmény | |
EP3697418A4 (fr) | Formulations de bromocriptine améliorées | |
PT3796975T (pt) | Derivados de sulfonilaminobenzamida | |
EP4007576A4 (fr) | Formulation antiarythmique | |
CL2018002038S1 (es) | Cultivador | |
LT3790612T (lt) | Inhaliatorius | |
IT201700095717A1 (it) | Composizione erbicida | |
EP3471546A4 (fr) | Formulation insecticide | |
EP3836980C0 (fr) | Formulation | |
EP3768322C0 (fr) | Formulation | |
ES1220991Y (es) | Ahumador | |
UA39310S (uk) | Культиватор | |
UA39308S (uk) | Культиватор | |
UA39334S (uk) | Культиватор |